Floatz logo

Campath 1H

Hemoglobin SC

Tami D. JohnN/ADormant
D
17/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
2/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hemoglobin SC cohort.

Asset / SponsorPhaseRating
Hydroxyurea
Nova Laboratories Limited
Phase 2BB
mp4co
Sangart
Phase 2B
Fludarabine
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Busulphan
Tami D. John
Phase 2CCC
PREDNISONE TABLETS
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2CCC

View all 19 →

Same molecule, other indications

Campath 1H is also rated in:

myelodysplastic syndromeDormant
C
Indicative ·
35 / 100
View asset →
leukemiaDormant
C
Indicative ·
35 / 100
View asset →
myeloproliferative neoplasmDormant
D
Indicative ·
31 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →